BioHarvest Sciences Inc.
BHST
$4.21
-$0.04-0.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.44% | 6.55% | -493.89% | 64.47% | 59.14% |
| Total Depreciation and Amortization | 26.98% | 9.69% | 14.01% | 97.52% | 57.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.06% | 33.50% | 292.80% | -90.54% | -86.01% |
| Change in Net Operating Assets | -303.17% | -3,100.00% | -0.29% | 102.22% | -26.76% |
| Cash from Operations | 5.73% | -18.87% | -51.98% | 9.57% | 20.21% |
| Capital Expenditure | -66.41% | 16.99% | 65.34% | -208.11% | -35.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | 100.00% | -- | -- |
| Cash from Investing | -67.00% | 9.96% | 69.37% | -206.31% | -37.46% |
| Total Debt Issued | -38.66% | -- | -- | -- | -51.87% |
| Total Debt Repaid | -565.84% | -158.54% | -115.13% | -71.32% | -970.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 508.92% | 6,036.59% | -48.20% | 2,791.38% | -64.99% |
| Foreign Exchange rate Adjustments | 183.72% | 480.00% | -170.59% | -33.33% | -159.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,290.21% | 401.63% | -81.18% | 152.68% | -109.96% |